nVerses Capital’s Aveanna Healthcare AVAH Stock Holding History

nVerses Capital’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-36,786	Closed	-$237K	–	309
2026 Q1	$237K	Buy	+36,786	New	+$284K	0.22%	224

Other funds holding AVAH

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

nVerses Capital's AVAH Position: Q2 2026 in Review

nVerses Capital sold out of Aveanna Healthcare (AVAH) in Q2 2026, closing a stake of 36,786 shares — an estimated $237K sold.

nVerses Capital first reported a position in AVAH in Q1 2026 and held it in 1 quarter. The position peaked at $237K in Q1 2026. 145 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

nVerses Capital reported no remaining Aveanna Healthcare position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 36,786 Aveanna Healthcare shares in Q2 2026, an estimated $237K.
nVerses Capital first reported a position in Aveanna Healthcare in Q1 2026 and held it in 1 quarter.
nVerses Capital's Aveanna Healthcare position peaked at $237K in Q1 2026.
145 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.